1. Chinese guidelines for treatment of adult primary immune thrombocytopenia

   • Xin-guang Liu
   • Xiao-chuan Bai
   • Ming Hou

   Guide Line 04 April 2018 Pages: 615 - 623

   

2. Guest editorial: Regulatory signaling in normal and abnormal hematopoiesis

   • Fumio Arai

   Progress in Hematology 04 May 2018 Pages: 624 - 626

3. Regulation of unfolded protein response in hematopoietic stem cells

   • Valgardur Sigurdsson
   • Kenichi Miharada

   Progress in Hematology 03 May 2018 Pages: 627 - 633

   

4. The hematopoietic stem cell diet

   • Adam C. Wilkinson
   • Satoshi Yamazaki

   Progress in Hematology 31 March 2018 Pages: 634 - 641

   

5. The significance and application of vascular niche in the development and maintenance of hematopoietic stem cells

   • Ryohichi Sugimura

   Progress in Hematology 30 March 2018 Pages: 642 - 645

   

6. The role of telomere binding molecules for normal and abnormal hematopoiesis

   • Kentaro Hosokawa
   • Fumio Arai

   Progress in Hematology 17 March 2018 Pages: 646 - 655

   

7. Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan

   • Yasutaka Ueda
   • Naoshi Obara
   • Haruhiko Ninomiya

   Original Article 30 January 2018 Pages: 656 - 665

   

8. miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb

   • Limin Xing
   • Wenyan Xu
   • Zonghong Shao

   Original Article 27 February 2018 Pages: 666 - 672

   

9. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms

   • Kyohei Misawa
   • Hajime Yasuda
   • Norio Komatsu

   Original Article 20 February 2018 Pages: 673 - 680

   

10. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan

    • Ayako Kamiunten
    • Kotaro Shide
    • Kazuya Shimoda

    Original Article 27 February 2018 Pages: 681 - 688

    

11. Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR–ABL kinase domain mutations

    • Kiran Naqvi
    • Jorge E. Cortes
    • Hagop Kantarjian

    Original Article 20 February 2018 Pages: 689 - 695

    

12. Favorable survival in lung transplant recipients on preoperative low-dose, as compared to high-dose corticosteroids, after hematopoietic stem cell transplantation

    • Seiichiro Sugimoto
    • Kentaroh Miyoshi
    • Takahiro Oto

    Original Article 30 January 2018 Pages: 696 - 702

    

13. Three coexisting lymphomas in a single patient: composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma

    • Atsujiro Nishioka
    • Hiroshi Ureshino
    • Shinya Kimura

    Case Report 25 November 2017 Pages: 703 - 708

    

14. 10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation

    • Katsumichi Fujimaki
    • Yukako Hattori
    • Hideaki Nakajima

    Case Report 29 November 2017 Pages: 709 - 711

    

15. Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia

    • Shin-ichiro Fujiwara
    • Yuya Shirato
    • Yoshinobu Kanda

    Case Report 28 November 2017 Pages: 712 - 715

    

16. Re: Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment

    • Kelsea Caruso
    • Michele Kanter

    Letter to the Editor 08 February 2018 Pages: 716 - 716

17. Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration

    • Hiroki Hosoi
    • Toshiki Mushino
    • Takashi Sonoki

    Letter to the Editor 18 April 2018 Pages: 717 - 719